FLOYD TAUB, M.D,
Medical Practice at Interlachen Dr, Silver Spring, MD

4873187, Oct 10, 1989

Mar 13, 1986

6/839074

Floyd Taub - Rockville MD

Digene Diagnostics, Incorporated - Silver Spring MD

C12Q 168, C12Q 170, C12Q 154, C12N 996

435 5

A cationic detergent having a positively charged group and a hydrophobic group is used to conjugate an enzymatically active enzyme molecule with a single-stranded nucleic acid molecule. The conjugate may be used to detect the presence of nucleic acid molecules having a nucleotide sequence which is complementary to that of the single-stranded molecule of the conjugate.

6451853, Sep 17, 2002

Feb 24, 1999

09/256762

Floyd E. Taub - Silver Spring MD
Carol H. Pontzer - Silver Spring MD

Dovetail Technologies, Inc - College Park MD

A61K 31275

514528, 514529

The present invention relates to methods of using peptide-like compounds, e. g. , aminocarboxylic acid amide derivatives, to bias the immune system toward producing, enhancing, or maintaining a polarized Th1 response, and to methods for treating diseases that improve by creating a Th1 response. The invention also relates to a method of treating diseases associated with elevated soluble TNF alpha levels by administering beta-alethine together with NAC to reduce soluble TNF alpha, and to a pharmaceutical composition comprising same. The present compounds can be used to modulate cytokines including IFN-gamma and IL-10.

6498150, Dec 24, 2002

Oct 7, 1999

09/414071

Floyd Taub - Silver Spring MD
Thomas J. Perun - Round Lake IL
Christopher K. Murray - Longmont CO
Randall J. Daughenbaugh - Longmont CO
Daniel Lednicer - Rockville MD

Dovetail Technologies, Inc. - College Park MD

A61K 31275

514 79, 546 22, 514212, 514277, 514408, 514 89, 514528, 514 91, 540484, 548400, 558166, 558170, 560312, 562102, 562109, 564123, 564193, 568 63

The present invention relates to peptide-like compounds, eg aminocarboxylic acid amide derivatives, and to methods of using same to stimulate cells of the immune system, bone marrow and other organs. The present compounds can be used to enhance vaccination, increase synthesis of and enhance function of blood cell components and enhance anti-neoplastic effects of various agents. The compounds of the invention can be used to produce a variety of further pharmacologic effects.

6414114, Jul 2, 2002

Feb 24, 1999

09/256765

Floyd E. Taub - Silver Spring MD
Christopher K. Murray - Boulder CO
Randall J. Daughenbaugh - Boulder CO
Daniel Lednicer - North Bethesda MD

Dovetail Technologies, Inc. - College Park MD

C07K 500

530330, 530326, 530327, 530328, 530329, 530331, 530332, 930 20, 930260

The present invention is directed to novel disulfides and thiols that are of up to about eighteen amino acids. One example, is a compound of the formula (1): A—B—C—S—S—D—E—F, wherein: A and F are selected from the group consisting of hydrogen, an amino acid, a dipeptide, a tripeptide, a modified polypeptide up to three amino acids long, and a carbobenzoxy groups, B and E are selected from the group consisting of an amino acid, a dipeptide, a tripeptide, and a modified polypeptide comprising up to and including three amino acids, C and D are selected from the group consisting of a modified polypeptide and a polypeptide comprising up to and including three amino acids, and S is the sulfur atom in the modified polypeptide and the polypeptide in C and D.

6166086, Dec 26, 2000

Feb 24, 1999

9/256763

Floyd E. Taub - Silver Spring MD

Dovetail Technologies, Inc. - College Park MD

A61K 3116

514626

The present invention relates to peptide-like compounds, eg aminocarboxylic acid amide derivatives, and to methods of using same in the field of general health care, for example, to improve resistance to stress, improve production of desired characteristics or useful products in animals, to increase weight gain, and to decrease feed efficiency. The invention has applications in the field of animal husbandry. It also relates to administering beta-alethine to improve feed efficiency in an animal, comprising administering to animal an amount of. beta. -alethine sufficient to reduce the amount of food required to increase a unit of weight in the animal.

2007014, Jun 21, 2007

Feb 2, 2007

11/701737

Floyd Taub - Silver Spring MD, US
Neal Koller - Annapolis MD, US
Char Albert - Timonium MD, US

A61K 31/185, A61K 36/18, A61K 33/00

424600000, 514553000, 424725000

The present invention comprises homeopathic preparations of compounds, methods for using such preparations and delivery systems for the treatment of disease symptoms through the administration of these homeopathic compositions.

2007021, Sep 13, 2007

May 10, 2007

11/801632

Floyd Taub - Silver Spring MD, US
Neal Koller - Annapolis MD, US
Char Albert - Timonium MD, US

A61K 33/30, A61K 9/127, A61K 9/20

424450000, 424464000, 424641000, 424642000

The present invention comprises homeopathic preparations of compounds, methods for using such preparations and delivery systems for the treatment of disease symptoms through the administration of these homeopathic compositions.

2008003, Feb 14, 2008

Feb 10, 2005

11/054093

Char Albert - Vero Beach FL, US
Floyd Taub - Silver Spring MD, US

A61K 31/315, A61K 31/24, A61K 45/00

514494000, 514534000, 514789000

An alternative method of delivery of homeopathic medicines by targeting delivery to the MALT's, especially of the intestinal tract and in high volumes.

4820630, Apr 11, 1989

Nov 23, 1984

6/674190

Floyd Taub - Rockville MD

Digene Diagnostics, Incorporated - MD

C12Q 168, C12Q 170, C12Q 128, C12Q 132

435 5

Lesions in genetic sequences, for example, the sickle cell anemia mutation in the beta globin gene, are detected by means of interactive labels in a nucleic acid hybridization assay. A signal is generated only if the labels are in physical proximity which is made dependent on whether a predetermined normal or abnormal sequence is present by exposure to appropriate conditions such as restriction enzyme digestion or stringent hybridization.